UA104739C2 - c-MET ANTIBODIES - Google Patents

c-MET ANTIBODIES

Info

Publication number
UA104739C2
UA104739C2 UAA201106322A UAA201106322A UA104739C2 UA 104739 C2 UA104739 C2 UA 104739C2 UA A201106322 A UAA201106322 A UA A201106322A UA A201106322 A UAA201106322 A UA A201106322A UA 104739 C2 UA104739 C2 UA 104739C2
Authority
UA
Ukraine
Prior art keywords
met
met antibodies
pathogencsis
antigen
mediated
Prior art date
Application number
UAA201106322A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джулиан Дейвис
Лин Лю
Цзижон Лу
Питер Эдвард Валльянкорт
Марк Эндрю Уэртингер
Вей Цзен
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Priority claimed from PCT/US2009/064881 external-priority patent/WO2010059654A1/en
Publication of UA104739C2 publication Critical patent/UA104739C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Provided are monoclonal antibodies, antigen-binding fragments thereof, and combinations of the foregoing, that bind to, and inhibit the activity of, c-Met, and that are effective in treating cancers and other diseases, disorders, or conditions where pathogencsis is mediated by c-Met.
UAA201106322A 2008-11-21 2009-11-18 c-MET ANTIBODIES UA104739C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11682508P 2008-11-21 2008-11-21
PCT/US2009/064881 WO2010059654A1 (en) 2008-11-21 2009-11-18 c-MET ANTIBODIES

Publications (1)

Publication Number Publication Date
UA104739C2 true UA104739C2 (en) 2014-03-11

Family

ID=52298737

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201106322A UA104739C2 (en) 2008-11-21 2009-11-18 c-MET ANTIBODIES

Country Status (1)

Country Link
UA (1) UA104739C2 (en)

Similar Documents

Publication Publication Date Title
JO3097B1 (en) c-Met Antibodies
UA103916C2 (en) Dkk-1 antibody
EA201200597A1 (en) MONOCLONAL PROTECTIVE ANTIBODIES AND THEIR APPLICATION
WO2011143318A3 (en) Anti-fgfr2 antibodies
EA202090031A2 (en) HUMAN ANTIBODIES AGAINST GFR3 AND WAYS OF THEIR APPLICATION
PH12017500864A1 (en) Anti-notch1 antibodies
WO2012078688A3 (en) Humanized antibodies to liv-1 and use of same to treat cancer
MY165273A (en) Anti-cd48 antibodies and uses thereof
TN2010000092A1 (en) Humanized cxcr5 antidodies, derivatives thereof and their uses
WO2010032059A3 (en) Antibodies directed to cd105 and uses thereof
EA201070730A1 (en) HUMANIZED ANTIBODIES SPECIFIC TO THE VILLEBRAND VON FACTOR
EA201690310A1 (en) HUMAN CD27 ANTIBODIES AND THEIR APPLICATION
NZ599737A (en) Il-17a antagonists
MX2014001766A (en) Neuregulin antibodies and uses thereof.
MX2018008882A (en) Composition and method for the diagnosis and treatment of iron-related disorders.
GB201109238D0 (en) Antibodies
EP2493930A4 (en) Compositions and methods for treating inflammatory disorders
EA201101643A1 (en) OPTIONS FOR THE USE OF IL-1β ANTIBODIES AND THEIR CONNECTING FRAGMENTS IN THE CARDIOVASCULAR SYSTEM
PH12015501360A1 (en) Bmp-6 antibodies
MX2023006777A (en) Compositions and methods comprising sfrp2 antagonists.
UA104739C2 (en) c-MET ANTIBODIES
WO2008118324A3 (en) Composition and method of treating cancer with an anti-uroplakin ib antibody
UA108207C2 (en) HIGH-AFIN HUMAN ANTIBODY TO HUMAN ANGIOPOETIN-2
UA112521C2 (en) ANTI-GDF8 ANTIBODY